Current Drug Trends and Emerging Drugs of Abuse
ID: 4103WEBMany new drugs are making local and national headlines such as K2/Spice and Bath Salts. This interactive webinar will discuss the latest developments and information regarding synthetic cannabinoids, MDPV, Mephedrone, Kratom, Salvia and other designer drugs that have been emerging over the past few years. Webinar participants will be introduced to the physiology of these drugs and how they can possibly impact, mimic and exacerbate mental health disorders such as anxiety and depressive disorders. Epidemiologic trends in drug abuse in both youth and adults will be discussed as will the latest trends from the New Jersey Division of Addiction Services. Webinar participants will participate in interactive discussions and exercises in differential diagnosis of similar symptoms produced by these emerging drugs of abuse and other mental health disorders. Patterns of use, abilities for urine detection, and other legal aspect regarding these emerging drugs will be discussed. [This webinar will complete your prescription opioid social work license requirement.]
Fee: $60.00
Continuing Ed. Hours (CEH): 3.0 Prescription Opioids
Webinar ObjectivesAt the conclusion of this webinar, participants will be able to:
Differentiate the major elements the Federal Government uses when classifying drugs from schedule 1 through schedule 5.
Identify at least two differences (in terms of negative effects) that occur with the ingestion of synthetic cannabinoids.
Identify which class of drugs synthetic cannabinoids & bath salts (synthetic cathinones) are classified under in the current version of the Diagnostic and Statistical Manual of Mental Disorders. Workshop participants will be able to list at least three negative side effects of each.
Differentiate differences that drugs of abuse such as Adderall, Oxycodone and Suboxone are classified under in the current version of the Diagnostic and Statistical Manual of Mental Disorders. Workshop participants will be able to list three negative side effects of each drug listed in this lecture.
List and describe two different best practice therapy approaches regarding counseling clients who are abusing these emerging substances of abuse.
Discuss current legal issues both locally and nationally as they relate to using these emerging substances of abuse.
Webinar Outline9:30 am - Welcome/Introduction
9:35 am - History of drug emergence and of being federally controlled
Overview of the scheduling of controlled substances
9:50 am - Opiates and Synthetic Opiates
History of classifying/prohibiting opiates
Opiates (Opium, Kratom) and synthetic opiates (Heroin, Oxycodone, Oxycontin)
Medicated assisted treatment for opiate addiction (Methodone, Suboxone, Vivitrol)
Cough Syrup with Codeine and Promethazine
Dangers/effects of use
11:05 am - MDPV/Mephedrone (Bath Salts)
What are bath salts and the history of their rise in popularity
Dangers/lethality/Poison Control Center data
Timeline, effects of use and relation to Ecstasy
Legal status in New Jersey, Pennsylvania and nationally
11:30 am - Synthetic Cannabinoids
History of classifying/prohibiting marijuana
Synthetic vs. naturally occurring cannabinoids
What are synthetic cannabinoids and the history of their rise in popularity
Classes of synthetic cannabinoids
Effects and dangers
Legal Status both locally and nationally
12:00 pm - Molly/Hallucinogens, Synthetic Hallucinogens, Ketamine and Detramethorphan
History of classifying/prohibiting hallucinogens
Ecstasy & new trends with MDMA (Molly)
Synthetic psilocybin, 2C-I, 2C-E and the new school of synthetic hallucinogens
NBOMes
Old School Trends (PCP, Ketamine)
Bromo-DragonFLY
Kratom
12:20 pm - Conclusion/Q&A
Target AudienceSocial Workers and Allied Health ProfessionalsContent LevelBeginner - AdvancedWebinar Completion RequirementsTo earn CE credit, social workers must log in at the scheduled time, attend the entire course and complete an online course evaluation. Certificates of completion will be emailed within 10 business days of course completion.
System Requirements
- Operating Systems: Windows XP or higher, MacOS 9 or higher, Android 4.0 or higher
- Internet Browser: Internet Explorer 9.0 or higher, Google Chrome, Firefox 10.0 or higher
- Broadband Internet connection: Cable, High-speed DSL & any other medium that is internet accessible.
About the InstructorGlenn Duncan, LPC, LCADC, CCS, ACS, has been working in the behavioral healthcare field for thirty years. He has lectured nationally on many topics including clinical supervision. He is a Licensed Professional Counselor, a Licensed Clinical Alcohol/Drug Counselor, a Certified Clinical Supervisor, and an Approved Clinical Supervisor. Glenn is currently the owner of Advanced Counselor Training, LLC. For 15 years (2003-2018) Glenn served as the Executive Director at Hunterdon Drug Awareness Program, Inc. (HDAP).